4//SEC Filing
GOLD DANIEL P PHD 4
Accession 0001209191-21-036188
CIK 0001262104other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 1:35 PM ET
Size
7.2 KB
Accession
0001209191-21-036188
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
- Exercise/Conversion
Common Stock
2021-05-25$2.52/sh+5,000$12,600→ 458,632 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-25−5,000→ 675,000 totalExercise: $2.52Exp: 2029-07-01→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.
- [F2]306,667 of the options are fully vested and currently exercisable. The remaining 368,333 options will vest in equal monthly installments through July 1, 2023.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001288233
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 1:35 PM ET
- Size
- 7.2 KB